We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$489M
AUM Growth
+$8.91M
(+1.9%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
42.69%
Holding
409
New
33
Increased
174
Reduced
80
Closed
38
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$4.55M |
| 2 |
iShares MBS ETF
MBB
|
+$3.43M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.15M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$2.87M |
| 5 |
Vanguard Total Bond Market
BND
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$8.24M |
| 2 |
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
|
+$7.89M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$3.83M |
| 4 |
Royal Caribbean
RCL
|
+$2.75M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.3% |
| 2 | Consumer Discretionary | 5.6% |
| 3 | Financials | 5.21% |
| 4 | Healthcare | 4.88% |
| 5 | Industrials | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Pfizer
PFE
$169B
| $115K | 0.02% |
3,626
+227
| +7% | +$7.4K |
2013 Q2
8 quarters
|
|
202
abrdn Life Sciences Investors
HQL
$521M
| $113K | 0.02% |
4,000
+2,000
| +100% | +$55.4K |
2014 Q4
2 quarters
|
|
203
Sysco
SYY
$40.7B
| $112K | 0.02% |
3,111
| – | – |
2013 Q2
8 quarters
|
|
204
iShares China Large-Cap ETF
FXI
$3.91B
| $112K | 0.02% |
2,425
+100
| +4% | +$4.95K |
2013 Q4
6 quarters
|
|
|
GWR
205
DELISTED
Genesee & Wyoming Inc.
GWR
| $109K | 0.02% |
1,425
+30
| +2% | +$2.64K |
2014 Q1
5 quarters
|
|
206
WisdomTree India Earnings Fund ETF
EPI
$1.83B
| $108K | 0.02% |
4,965
+1,015
| +26% | +$22.3K |
2013 Q4
6 quarters
|
|
|
AGU
207
DELISTED
Agrium
AGU
| $107K | 0.02% |
1,008
| – | – |
2013 Q4
6 quarters
|
|
208
DELISTED
BlackRock MuniVest Fund II
MVT
| $106K | 0.02% |
7,150
+2,500
| +54% | +$39K |
2014 Q2
4 quarters
|
|
209
Union Pacific
UNP
$173B
| $105K | 0.02% |
1,102
-4,496
| -80% | -$469K |
2013 Q2
8 quarters
|
|
210
Amazon
AMZN
$2.73T
| $105K | 0.02% |
4,840
| – | – |
2014 Q4
2 quarters
|
|
211
American Express
AXP
$215B
| $104K | 0.02% |
1,338
-356
| -21% | -$28.2K |
2013 Q2
8 quarters
|
|
212
SLB Ltd
SLB
$73.5B
| $100K | 0.02% |
1,161
-125
| -10% | -$11.3K |
2013 Q2
8 quarters
|
|
213
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.05B
| $99K | 0.02% |
5,000
| – | – |
2014 Q3
3 quarters
|
|
214
Novartis
NVS
$287B
| $98.7K | 0.02% |
1,120
| – | – |
2014 Q4
2 quarters
|
|
215
KKR Income Opportunities Fund
KIO
$407M
| $98.3K | 0.02% |
6,240
+3,500
| +128% | +$56.9K |
2014 Q3
3 quarters
|
|
216
Bio-Rad Laboratories Class A
BIO
$9.63B
| $97.1K | 0.02% |
645
| – | – |
2013 Q3
7 quarters
|
|
|
YHOO
217
DELISTED
Yahoo Inc
YHOO
| $96.3K | 0.02% |
2,450
| – | – |
2013 Q4
6 quarters
|
|
218
Gabelli Equity Trust
GAB
$1.79B
| $93.9K | 0.02% |
15,468
+5,156
| +50% | +$32.4K |
2013 Q2
8 quarters
|
|
219
Universal Health Realty Income Trust
UHT
$536M
| $92.9K | 0.02% |
2,000
| – | – |
2014 Q1
5 quarters
|
|
|
XLNX
220
DELISTED
Xilinx Inc
XLNX
| $92.9K | 0.02% |
2,104
-228
| -10% | -$10.3K |
2014 Q1
5 quarters
|
|
221
American Airlines Group
AAL
$8.23B
| $89.1K | 0.02% |
2,230
| – | – |
2014 Q2
4 quarters
|
|
222
Avnet
AVT
$7.53B
| $85K | 0.02% |
2,068
| – | – |
2013 Q2
8 quarters
|
|
223
Philip Morris
PM
$316B
| $85K | 0.02% |
1,060
-203
| -16% | -$16.7K |
2013 Q2
8 quarters
|
|
224
Ameriprise Financial
AMP
$44.8B
| $85K | 0.02% |
680
| – | – |
2013 Q2
8 quarters
|
|
|
AGN
225
DELISTED
Allergan plc
AGN
| $83.5K | 0.02% |
275
| – | – |
2014 Q2
4 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2015 Portfolio in Review
As of Q2 2015, Capital Analysts LLC held 409 positions worth $489M, up 1.9% from $480M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Capital Analysts LLC deployed $14.9M of net new capital in Q2 2015, opening 33 new positions and adding to 174 existing holdings. Its largest new stake was iShares MBS ETF: 31,326 shares worth $3.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 66% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $8.24M trimmed.
- Capital Analysts LLC's largest Q2 2015 buy was iShares MBS ETF: 31,326 shares worth $3.4M.
- Capital Analysts LLC added most to iShares TIPS Bond ETF in Q2 2015, an estimated $4.55M increase.
- Capital Analysts LLC's biggest Q2 2015 reduction was iShares Russell 3000 ETF, cutting an estimated $8.24M.
- Capital Analysts LLC fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2015, selling an estimated $3.83M.
- Capital Analysts LLC's ten largest holdings make up 43% of its $489M portfolio in Q2 2015.
- Capital Analysts LLC opened 33 new positions and closed 38 in Q2 2015.
- Capital Analysts LLC's portfolio value rose 1.9% quarter-over-quarter to $489M.
Based on Capital Analysts LLC's 13F filing for Q2 2015, filed 14 Aug 2015.